Month: August 2022

As the number of monkeypox cases swells to 2,171 in France, the region most hard hit, Paris, has opened a vaccination centre dedicated entirely to dispensing the smallpox jab, which has so far been the most effective way to prevent the virus.

Paris’s 13^th Arrondissement is the new home to a dedicated major monkeypox vaccination centre, a modest two room facility with a waiting room and one small inoculation area located in the Edison Community Health Centre.

Monkeypox, a cousin of smallpox, has made headlines recently as the number of confirmed cases swells worldwide. France has 2,171 cases, more than half of which are in Paris.

Patients who wish to be jabbed must have made an appointment through the medical appointment website Doctolib, and are then asked to fill out a form, as well as present a valid ID. At present, the centre is prioritising the most at-risk populations, including gay men, transexual people, those with multiple sex partners and sex workers. No plans are pending to open wide-spread vaccinations to the general public.

Though it is being touted as a “gay disease”, this is absolutely not the case according to Dr Yannick Simonin, a virologist and lecturer specialising in emerging viruses at the University of Montpellier. Dr Simonin told Le Monde that “Anyone who has close physical contact with another person who has contracted monkeypox is at risk, regardless of sexual orientation. Monkeypox does not only concern this (homosexual) community, even though the number of cases within it is currently over-represented.”

The French government has said they will be taking on more people to administer jabs soon, and will look to doctors, nurses and medical students to fulfil that need. Once a person has been vaccinated, they will get booked in for a second dose 28 days after the first, though authorities may have to extend this time limit.

The number of cases in France is doubling every fortnight according to Samuel Etien, a medical student and volunteer at the centre, adding that “no similar situation of monkeypox infection has occurred in Europe to date.

If a patient comes in displaying monkeypox symptoms, they will be asked to return home to isolate for the duration of the illness, usually two to four weeks. Symptoms include a rash with large, hardened spots with pus or crusts forming in the areas of the mouth or palms of the hands. Spots often show up all at once. Mouth and anal pain may accompany the spots. Other common signs are a red rash on the anal or oral mucous membranes, a cluster of pimples, influenza-like symptoms like fever and achiness, and swollen lymph nodes in the neck and armpits.

Anne Souyris, the deputy mayor of Paris in charge of public health, said there are plans to expand the vaccine centre “as much as possible”. She says that other venues could be opened if there are enough personnel to staff them and that she hopes that “this epidemic will be contained, or at least slowed down, by the end of the summer.”

The French government has made the jab available at over 100 vaccination centres across the country.

The latest figures from the government show that Covid circulation is still dropping in Monaco, while researchers have pointed to a potentially more effective vaccine patch.

Things are looking up on the Covid front in the Principality, with last week seeing only 117 new positive cases, down from 180 the week before. Along with this, hospitalisations are down from 29 to 19 patients, though there are currently two people receiving treatment in intensive care, a rise from zero the previous week.

Only 56 people are being monitored by the Home Monitoring Centre, also down this week from 85.

Monaco performed 1,544 PCR and antigen tests in the week ending 31^st July, less than 1,875 the previous week and far below the 2,550 tests carried out during the peak of the virus in early July. The positivity rate has dropped to 17.28%, compared to 20.3%.

In the Alpes-Maritimes, the incidence rate remains rather high at 606, more than the French national average of 500, while the positivity rate sits at 22.9%.

To add to the positive spin, there have been reports out of Australia’s University of Queensland, who are in partnership with Brisbane-based biotech company Vaxxas, that the needle-free Covid-19 vaccine patch could offer more robust protection against the virus than the jab.

The researchers analysed the Hexapro SARS-CoV-2 spike vaccine using Vaxxas high-density microarray patch (HD-MAP) technology.

“The high-density microarray patch is a vaccine delivery platform that precisely delivers the vaccine into the layers of the skin which are rich in immune cells,” said Christopher McMillan of Queensland University in a statement.

“We found that vaccination via a patch was approximately 11 times more effective at combatting the Omicron variant when compared with the same vaccine administered via a needle.”